(Q61443745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

0 references

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

author name string

Jana de Sostoa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Carlos Alberto Fajardo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Rafael Moreno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Maria D Ramos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Martí Farrera-Sal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

language of work or name

English

0 references

publication date

25 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

Journal for Immunotherapy of Cancer

20 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/s40425-019-0505-4

20 April 2020

exact match

0 references

cites work

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

1 reference

12 December 2020

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

12 December 2020

Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct

1 reference

12 December 2020

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

1 reference

12 December 2020

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells

1 reference

12 December 2020

Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow

1 reference

12 December 2020

The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens

1 reference

12 December 2020

Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts

1 reference

12 December 2020

Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth

1 reference

12 December 2020

Minimal RB-responsive E1A promoter modification to attain potency, selectivity, and transgene-arming capacity in oncolytic adenoviruses.

1 reference

12 December 2020

Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy

1 reference

12 December 2020

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

1 reference

12 December 2020

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

1 reference

12 December 2020

Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia.

1 reference

12 December 2020

Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia

1 reference

12 December 2020

Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma

1 reference

12 December 2020

Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.

1 reference

12 December 2020

T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy

1 reference

12 December 2020

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy

1 reference

12 December 2020

Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity

1 reference

12 December 2020

Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information

1 reference

12 December 2020

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

1 reference

12 December 2020

Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.

1 reference

12 December 2020

A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice

1 reference

12 December 2020

Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery

1 reference

12 December 2020

The biology and function of fibroblasts in cancer

1 reference

12 December 2020

Oncolytic Adenoviral Delivery of an EGFR-Targeting T-cell Engager Improves Antitumor Efficacy

1 reference

12 December 2020

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies.

1 reference

12 December 2020

Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies

1 reference

12 December 2020

Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing

1 reference

12 December 2020

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.

1 reference

12 December 2020

Targeted BiTE expression by an oncolytic vector augments therapeutic efficacy against solid tumors.

1 reference

12 December 2020

Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus-Driven Production of a Bispecific T-cell Engager

1 reference

12 December 2020

Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation.

1 reference

12 December 2020

10.1186/S40425-019-0505-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30683154%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference